Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Objective Response Rate”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Testing effectiveness (Phase 2)Looking for participantsNCT07150247
What this trial is testing

Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer

Who this might be right for
BRAF V600 Colorectal Cancer
Sun Yat-sen University 20
Very early researchActive Not RecruitingNCT06572956
What this trial is testing

Clinical Study on the Safety and Efficacy of CAR-T/CAR-NK Cells in the Treatment of Recurrent Refractory or Unresectable Solid Tumors

Who this might be right for
Safety and Efficacy of Cellular Drugs, Objective Response Rate of Subjects, Etc
The Second Hospital of Shandong University 10
Testing effectiveness (Phase 2)Looking for participantsNCT06125834
What this trial is testing

Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Progressive Disease After TKIs or HP Therapy

Who this might be right for
Advanced Breast CancerObjective Response RateTrastuzumab Emtansine
The First Affiliated Hospital with Nanjing Medical University 36
Testing effectiveness (Phase 2)UnknownNCT04664244
What this trial is testing

Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma

Who this might be right for
Recurrent Cervical CarcinomaRadiotherapyEpidermal Growth Factor Receptor+4 more
Lei Li 43
Large-scale testing (Phase 3)Temporarily pausedNCT05503108
What this trial is testing

Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer

Who this might be right for
Fasting Mimicking DietHER2-negative Breast CancerHormone Receptor-positive Breast Cancer+3 more
Leiden University Medical Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT04512534
What this trial is testing

Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Fudan University 51
Testing effectiveness (Phase 2)UnknownNCT01192230
What this trial is testing

Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Fudan University 30
Testing effectiveness (Phase 2)WithdrawnNCT02014831
What this trial is testing

Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)

Who this might be right for
Squamous Cell Carcinoma of the Penis
Centre Leon Berard
Testing effectiveness (Phase 2)UnknownNCT01192243
What this trial is testing

Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients

Who this might be right for
ToxicityNon-small Cell Lung Cancer
Fudan University 68
Testing effectiveness (Phase 2)UnknownNCT02124317
What this trial is testing

Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Chinese PLA General Hospital 60
Testing effectiveness (Phase 2)UnknownNCT04635956
What this trial is testing

Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas

Who this might be right for
ChemotherapyAnti-pd-1 AntibodyCervical Neuroendocrine Carcinoma+4 more
Lei Li 20
Not applicableUnknownNCT03336554
What this trial is testing

Epigenetic Biomarker for Osteosarcoma

Who this might be right for
Histologic Response (Tumor Necrosis Rate)Objective Response Rate for Neoadjuvant Chemotherapy, ORRProgression-free Survival, PFS+1 more
Peking University People's Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT01466868
What this trial is testing

Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Centre Leon Berard 22
Testing effectiveness (Phase 2)Looking for participantsNCT07320508
What this trial is testing

Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study

Who this might be right for
Adenoid Cystic CarcinomaSinonasal CarcinomaEpirubicin
Eye & ENT Hospital of Fudan University 100
Large-scale testing (Phase 3)Looking for participantsNCT06520345
What this trial is testing

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 430
Testing effectiveness (Phase 2)UnknownNCT04670978
What this trial is testing

Abraxane With Bevacizumab Biosimilar in Patients With Recurrent, Platinum-resistant Epithelial Ovarian Cancer

Who this might be right for
Objective Response Rate
Shandong University 96
Large-scale testing (Phase 3)UnknownNCT04741438
What this trial is testing

Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype

Who this might be right for
Sarcoma
Centre Leon Berard 96
Testing effectiveness (Phase 2)Study completedNCT01915589
What this trial is testing

Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC)

Who this might be right for
Carcinoma, Hepatocellular
Bayer 16
Testing effectiveness (Phase 2)Study completedNCT00235937
What this trial is testing

Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex

Who this might be right for
Breast Cancer
AstraZeneca 45
Early research (Phase 1)Study completedNCT00481728
What this trial is testing

Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.

Who this might be right for
Overactive Bladder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 28
Load More Results